Front Row Advisors LLC Pfizer Inc Transaction History

Front Row Advisors LLC

$271 Million
Q3 2024

A detailed history of Front Row Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Front Row Advisors LLC holds 6,098 shares of PFE stock, worth $151,596. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,098

Previous 13,613 55.2%

Holding current value

$151,596

Previous $380,000 53.68%

% of portfolio

0.07%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $208,165 - $235,895	-7,515 Reduced 55.2%	6,098 $176,000
Q2 2024 Aug 15, 2024	BUY	$25.26 - $29.6 $38,066 - $44,607	1,507 Added 12.45%	13,613 $380,000
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $1.1 Million - $1.26 Million	-42,471 Reduced 77.82%	12,106 $335,000
Q4 2023 Feb 15, 2024	SELL	$26.13 - $33.94 $259,732 - $337,363	-9,940 Reduced 15.41%	54,577 $1.57 Million
Q3 2023 Nov 15, 2023	BUY	$32.09 - $37.51 $6,321 - $7,389	197 Added 0.31%	64,517 $2.14 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $16,253 - $18,805	450 Added 0.7%	64,320 $2.36 Million
Q1 2023 May 22, 2023	BUY	$39.39 - $51.28 $2.41 Million - $3.14 Million	61,264 Added 2350.88%	63,870 $2.61 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $2.43 Million - $3.16 Million	-61,640 Reduced 95.94%	2,606 $6.39 Million
Q4 2022 Feb 15, 2023	SELL	$41.75 - $54.5 $98,822 - $129,001	-2,367 Reduced 3.55%	64,246 $3.29 Million
Q3 2022 Nov 15, 2022	SELL	$43.76 - $53.42 $5,251 - $6,410	-120 Reduced 0.18%	66,613 $2.92 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $9,864 - $11,696	-212 Reduced 0.32%	66,733 $3.5 Million
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $83,539 - $103,515	1,826 Added 2.8%	66,945 $3.47 Million
Q4 2021 Mar 09, 2022	SELL	$41.32 - $61.25 $30,039 - $44,528	-727 Reduced 1.1%	65,119 $3.85 Million
Q3 2021 Nov 03, 2021	BUY	$39.25 - $50.42 $3,375 - $4,336	86 Added 0.13%	65,846 $2.83 Million
Q2 2021 Aug 23, 2021	BUY	$35.91 - $40.68 $372,602 - $422,095	10,376 Added 18.73%	65,760 $3.21 Million
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $23,744 - $26,778	709 Added 1.3%	55,384 $2.01 Million
Q4 2020 Feb 25, 2021	SELL	$33.47 - $42.56 $34,741 - $44,177	-1,038 Reduced 1.86%	54,675 $2.01 Million
Q3 2020 Nov 30, 2020	SELL	$31.75 - $37.25 $51,816 - $60,792	-1,632 Reduced 2.85%	55,713 $2.07 Million
Q2 2020 Aug 17, 2020	SELL	$30.12 - $36.54 $26,415 - $32,045	-877 Reduced 1.51%	57,345 $1.88 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $83,225 - $118,910	3,079 Added 5.58%	58,222 $2.23 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $46,548 - $52,827	-1,414 Reduced 2.5%	55,143 $2.16 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $35,836 - $46,469	1,103 Added 1.99%	56,557 $2.03 Million
Q2 2019 Aug 27, 2019	SELL	$36.98 - $41.52 $16,751 - $18,808	-453 Reduced 0.81%	55,454 $2.4 Million
Q1 2019 May 17, 2019	SELL	$37.5 - $41.2 $10,875 - $11,948	-290 Reduced 0.52%	55,907 $2.37 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $30,275 - $34,517	-787 Reduced 1.38%	56,197 $2.45 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $52,325 - $63,467	-1,518 Reduced 2.59%	56,984 $2.42 Million
Q2 2018 Jul 31, 2018	BUY	$32.98 - $35.16 $26,680 - $28,444	809 Added 1.4%	58,502 $2.22 Million
Q1 2018 May 21, 2018	BUY	$31.91 - $37.02 $19,241 - $22,323	603 Added 1.06%	57,693 $2.05 Million
Q4 2017 Feb 01, 2018	BUY	$33.26 - $35.29 $1.9 Million - $2.01 Million	57,090	57,090 $2.07 Million

Others Institutions Holding PFE

# of Institutions

3,255

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Account

Front Row Advisors LLC Pfizer Inc Transaction History